Sponsor
Astellas Pharma Inc
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Astellas Pharma Inc appears in 190 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
60 shownA Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsNCT07094204 · lead sponsor · 2025-07-25
RECRUITINGA Study to Find a Suitable Dose of ASP4396 in Adults With Solid TumorsNCT06364696 · lead sponsor · 2024-04-16
TERMINATEDA Study to Compare the Use of Diabetes Treatment Support System (BAP0527 and Blood Glucose Meter) in Addition to Daily Practice and Treatment With Daily Practice and Treatment Alone in Patients With Type 2 Diabetes MellitusNCT06156696 · lead sponsor · 2024-02-16
COMPLETEDA Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During SurgeryNCT05457842 · lead sponsor · 2022-08-10
TERMINATEDJapan Post-Marketing Surveillance for Peficitinib to Assess Safety and Effectiveness in the Patients With Rheumatoid ArthritisNCT03971253 · lead sponsor · 2019-09-02
COMPLETEDA Safety and Efficacy Study of Enzalutamide in Indian Patients With Progressive Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel-Based ChemotherapyNCT03641560 · lead sponsor · 2018-09-19
COMPLETEDA Study to Evaluate the Efficacy and Safety of ASP5094 in Patients With Rheumatoid Arthritis on MethotrexateNCT03257852 · lead sponsor · 2017-09-29
COMPLETEDStudy on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate CancerNCT02918968 · lead sponsor · 2016-11-02
COMPLETEDA Study to Evaluate the Efficacy and Safety of ASP1707 in Postmenopausal Female Patients With Rheumatoid Arthritis Taking MethotrexateNCT02884635 · lead sponsor · 2016-09-16
COMPLETEDA Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes MellitusNCT02897219 · lead sponsor · 2016-08-29
COMPLETEDStudy of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin TherapyNCT02847091 · lead sponsor · 2016-07-29
COMPLETEDPharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes MellitusNCT02529449 · lead sponsor · 2015-09-01
COMPLETEDA Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR MutationsNCT02500927 · lead sponsor · 2015-06-25
TERMINATEDStudy to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive EpisodesNCT02362412 · lead sponsor · 2015-02-18
COMPLETEDLong-Term Specified Drug Use-Results Survey for Xtandi CapsuleNCT02669771 · lead sponsor · 2014-11-30
COMPLETEDPost-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)NCT02291874 · lead sponsor · 2014-10-08
COMPLETEDA Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDsNCT02308163 · lead sponsor · 2014-08-08
COMPLETEDA Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) TreatmentNCT02305849 · lead sponsor · 2014-07-25
COMPLETEDSpecified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes PatientsNCT02479399 · lead sponsor · 2014-07-17
COMPLETEDAn Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer ParticipantsNCT02294461 · lead sponsor · 2014-04-23
COMPLETEDThe Survey of Ipragliflozin Treatment in Elderly type2 Diabetes PatientsNCT02297620 · lead sponsor · 2014-04-01
COMPLETEDA Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes MellitusNCT02175784 · lead sponsor · 2014-03-31
COMPLETEDAn Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) MutationsNCT02192697 · lead sponsor · 2014-01-23
TERMINATEDA Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate CancerNCT01964170 · lead sponsor · 2013-08-13
COMPLETEDSpecified Drug Use-results Survey of Betanis TabletsNCT01898624 · lead sponsor · 2012-12-04
COMPLETEDLong-term Study of FK949E in Elderly Bipolar Disorder PatientsNCT01737268 · lead sponsor · 2012-10-29
COMPLETEDSpecial Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis PatientsNCT01870908 · lead sponsor · 2012-08-01
COMPLETEDA Study to Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to MethotrexateNCT01554696 · lead sponsor · 2012-07-06
COMPLETEDA Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015KNCT01638013 · lead sponsor · 2012-06-13
COMPLETEDA Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes PatientsNCT01672762 · lead sponsor · 2012-05-25
COMPLETEDA Study to Assess the Efficacy and Safety of ASP1941 in Asian Subjects With Type 2 Diabetes MellitusNCT01514838 · lead sponsor · 2012-04-23
TERMINATEDComparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive DisorderNCT01919008 · lead sponsor · 2012-03-26
COMPLETEDA Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis SubjectsNCT01649999 · lead sponsor · 2012-03-01
COMPLETEDA Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive EpisodesNCT01725308 · lead sponsor · 2012-02-07
COMPLETEDStudy to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive DisorderNCT01725282 · lead sponsor · 2011-12-14
COMPLETEDA Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)NCT01511003 · lead sponsor · 2011-12-05
COMPLETEDA Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes PatientsNCT01505426 · lead sponsor · 2011-11-28
COMPLETEDA Study to Assess the Safety of Continued Administration of MDV3100 in Subjects With Prostate Cancer Who Showed Benefit From Prior Exposure to MDV3100NCT01534052 · lead sponsor · 2011-10-21
COMPLETEDEfficacy Confirmation Study of CDP870 in Early Rheumatoid ArthritisNCT01451203 · lead sponsor · 2011-10-11
COMPLETEDA Single Oral Dose Study of ASP015K in Healthy Volunteers Assessing the Relative Bioavailability Across Three Tablet Strengths From a New Formulation of ASP015KNCT01486017 · lead sponsor · 2011-09-01
COMPLETEDA Single Oral Dose Study to Compare the Bioavailability Between Two Different Tablet Formulations and Assess if There is a Food Effect With the New FormulationNCT01484964 · lead sponsor · 2011-09-01
COMPLETEDA Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of DonepezilNCT01406145 · lead sponsor · 2011-06-16
COMPLETEDA Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone TherapyNCT01302041 · lead sponsor · 2011-05-06
COMPLETEDStudy of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) GeneNCT01221077 · lead sponsor · 2011-04-08
COMPLETEDA Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate CancerNCT01288911 · lead sponsor · 2011-03-22
COMPLETEDPhase 2 Study of Maintenance OSI-906 Plus Erlotinib (Tarceva®), or Placebo Plus Erlotinib in Patients With Nonprogression Following 4 Cycles of Platinum-based ChemotherapyNCT01186861 · lead sponsor · 2011-03-04
COMPLETEDPhase I/II Study of ASP9521 in Castrate-Resistant Prostate Cancer (CRPC) PatientsNCT01352208 · lead sponsor · 2011-03-01
TERMINATEDA Study to Assess the Receptor Occupancy of CD86 and CD80 in Subjects With Rheumatoid Arthritis Initiating AbataceptNCT01339481 · lead sponsor · 2011-02-01
COMPLETEDA Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without SteroidsNCT01304836 · lead sponsor · 2011-01-22
COMPLETEDA Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal ImpairmentNCT01316094 · lead sponsor · 2011-01-18
COMPLETEDA Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic PatientsNCT01316107 · lead sponsor · 2011-01-15
COMPLETEDLong-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870NCT02586246 · lead sponsor · 2011-01-01
COMPLETEDA Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer PatientsNCT01284920 · lead sponsor · 2010-11-02
COMPLETEDOral Multiple-dose Study in Patients With Major Depressive DisorderNCT01924520 · lead sponsor · 2010-11-01
COMPLETEDA Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic PatientsNCT01242202 · lead sponsor · 2010-10-21
COMPLETEDA Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic PatientsNCT01242228 · lead sponsor · 2010-10-21
COMPLETEDStudy to Find Maintenance Dose for Periodic Administration of ASP3550NCT01261572 · lead sponsor · 2010-10-12
COMPLETEDA Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate CancerNCT01228760 · lead sponsor · 2010-10-01
COMPLETEDA Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic PatientsNCT01242215 · lead sponsor · 2010-09-17
COMPLETEDA Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic PatientsNCT01225081 · lead sponsor · 2010-09-15
COMPLETEDSponsor roles
lead sponsor117
collaborator73
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.